ExpressPoints: Diagnostic Testing for HER2, HER3, and TROP2 and Treatment Implications in Metastatic Breast Cancer

From Clinical Care Options (CCO), on-demand Webcast with Lee Schwartzberg, MD, FACP, and Ruth O’Regan, MD, on optimal treatment of breast cancer brain metastases

Ruth O'Regan, MD Lee Schwartzberg, MD, FACP Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 1.25 Medical Knowledge MOC point(s) Released: January 22, 2021 Expired: January 21, 2022

Overview + Surgery and Local Radiation Therapy for Managing BCBM

Current Evidence on Therapeutic Approaches to BCBM: HER2-Positive Disease

Current Evidence on Therapeutic Approaches to BCBM: HER2-Negative Disease

Expert video from live CCO Webinar on using immune checkpoint inhibitors and antibody–drug conjugates for early-stage through metastatic TNBC

Heather McArthur, MD, MPH
Program Director Kevin Kalinsky, MD, MS Rita Nanda, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 1.25 Medical Knowledge MOC point(s) Released: January 22, 2021 Expired: January 21, 2022

Immune Checkpoint Inhibitor in Advanced TNBC (26 minutes)

Immune Checkpoint Inhibitor in Early-Stage TNBC (27 minutes)

Antibody–Drug Conjugates in TNBC (26 minutes)

Commentary by Dr. Kevin Kalinsky: Sequencing checkpoint inhibitors and sacituzumab govitecan in advanced TNBC with vs without BRCA mutation, from CCO

Kevin Kalinsky, MD, MS Released: December 23, 2020

Downloadable slideset with key data from the 2020 SABCS Virtual Symposium from Clinical Care Options (CCO)

Sara Hurvitz, MD, FACP Joyce O'Shaughnessy, MD Released: December 18, 2020